Riskpilot← Back to searchSign inGet full accessCurex Gruppen AB
ABActiveOrg 5564417656Dalagatan 6Day spa, sauna and steam bath activities · NACE 9623Est. 19925 employees
Revenue 2024
SEK 4,3M
+11% vs 2023
EBITDA margin
3.7%
+126% vs 2023
Equity ratio
29.3%
Financial strength
Net profit 2024
SEK 147K
+343% vs 2023
| Revenue | SEK 4,3M | +11% |
| EBITDA | SEK 160K | +126% |
| Net profit | SEK 147K | +343% |
| Total assets | SEK 1,2M | -21% |
| Equity | SEK 365K | +67% |
| Employees | 5 | — |
Legal name
Curex Gruppen AB
Org number
5564417656
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
4 februari 1992
Share capital
SEK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva handel och förmedling av produkter och tjänster inom friskvårdsområdet likväl som utbildning och konsultverksamhet inom friskvård, att äga och förvalta värdepapper och därmed förenlig verksamhet.
Address
Dalagatan 6
Phone
+4686516700
Email
info@curexgruppen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 933 | 2 185 | 2 840 | 3 871 | 4 291 |
| Staff expenses | — | — | −729 | −1 565 | −2 048 |
| EBITDA | 95 | −522 | 83 | 71 | 160 |
| Depreciation & amort. | −56 | −0 | — | — | — |
| EBIT | 39 | −522 | 83 | 71 | 160 |
| Net financials | 24 | −347 | −5 | −38 | −13 |
| Profit before tax | 64 | −692 | 79 | 33 | 147 |
| Tax | −23 | −0 | — | — | — |
| Net profit | 41 | −692 | 79 | 33 | 147 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 908 | 1 210 | 1 389 | 1 586 | 1 247 |
| Equity | 581 | 106 | 185 | 218 | 365 |
| Long-term debt | 376 | 448 | 506 | 502 | 94 |
| Short-term debt | 951 | 656 | 698 | 866 | 789 |
| Total debt | 1 327 | 1 104 | 1 204 | 1 368 | 882 |
EBITDA margin
3.7%
This company
15.8%
Market median
-77% vs market
20202024
Equity ratio
29.3%
This company
38.2%
Market median
-23% vs market
20202024
Return on equity
40.3%
This company
18.4%
Market median
+119% vs market
20202024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20202024
Asset turnover
3.44×
This company
1.12×
Market median
+207% vs market
20202024
Debt / equity
2.42×
This company
0.62×
Market median
-290% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JR Audit | Audit | 2026 |
SM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curex Gruppen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Rolf Hultelid | Audit | 0 companies |
| Susanne Marie Berglund | Chief Executive Officer | 0 companies |
| Mari Christina Grape Vesterlund | Deputy Board Member | 0 companies |
| Carl Petrus Olovsson Berglund | Deputy Board Member | 0 companies |